pGL3-321/+120 mut1&2
(Plasmid
#35546)
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 35546 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepGL3-basic
-
Backbone manufacturerPromega
- Backbone size w/o insert (bp) 4818
- Total vector size (bp) 5250
-
Vector typeLuciferase
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert namepromoter region of miR200b-200a-429 genomic cluster
-
Alt nameMIRN200B
-
Alt nameMIRN200A
-
Alt nameMIRN429
-
SpeciesH. sapiens (human)
-
Insert Size (bp)441
-
MutationT to G at position -52 and T to G at position -96 in promoter
-
GenBank ID406984 406983
-
Entrez GeneMIR200B (a.k.a. MIRN200B, mir-200b)
-
Entrez GeneMIR429 (a.k.a. MIRN429, hsa-mir-429, mir-429)
-
Entrez GeneMIR200A (a.k.a. MIRN200A, mir-200a)
- Promoter none
-
Tag
/ Fusion Protein
- luciferase (C terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NheI (not destroyed)
- 3′ cloning site BglII (not destroyed)
- 5′ sequencing primer CTAGCAAAATAGGCTGTCCC
- 3′ sequencing primer CTTTATGTTTTTGGCGTCTTCCA (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pGL3-321/+120 mut1&2 was a gift from Greg Goodall (Addgene plasmid # 35546 ; http://n2t.net/addgene:35546 ; RRID:Addgene_35546) -
For your References section:
A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, Goodall GJ. Cancer Res. 2008 Oct 1;68(19):7846-54. 10.1158/0008-5472.CAN-08-1942 PubMed 18829540